Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment

Christian Rolfo*, Judith de Vos-Geelen, Nicolas Isambert, L. Rhoda Molife, Jan H. M. Schellens, Jacques De Greve, Luc Dirix, Peter Grundtvig-Sorensen, Guy Jerusalem, Karin Leunen, Morten Mau-Sorensen, Ruth Plummer, Maria Learoyd, Wendy Bannister, Anitra Fielding, Alain Ravaud

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1165-1174
Number of pages10
JournalClinical Pharmacokinetics
Volume58
Issue number9
DOIs
Publication statusPublished - Sep 2019

Keywords

  • INHIBITOR
  • CANCER

Cite this